Issue 6/2014
Content (5 Articles)
Review
Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors—Fighting Diabetes from a New Perspective
Theodoros P. Angelopoulos, John Doupis
Original Research
24-Hour Efficacy of Travoprost/Timolol BAK-Free Versus Latanoprost/Timolol Fixed Combinations in Patients Insufficiently Controlled with Latanoprost
Anastasios G. P. Konstas, Irini C. Voudouragkaki, Kostantinos G. Boboridis, Anna-Bettina Haidich, Eleni Paschalinou, Theodoros Giannopoulos, Nikolaos D. Dragoumis, Alexandros K. Makridis, Malik Y. Kahook
Original Research
Safety and Tolerability of Tapentadol Extended Release in Moderate to Severe Chronic Osteoarthritis or Low Back Pain Management: Pooled Analysis of Randomized Controlled Trials
Mila Etropolski, Brigitte Kuperwasser, Maren Flügel, Thomas Häufel, Bernd Lange, Christine Rauschkolb, Frank Laschewski
Original Research
Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial
Takashi Kadowaki, Masakazu Haneda, Nobuya Inagaki, Yasuo Terauchi, Atsushi Taniguchi, Kazuki Koiwai, Henning Rattunde, Hans J. Woerle, Uli C. Broedl
Open Access
Original Research
The Clinical Impact of Different Coagulometers on Patient Outcomes
Jan Leendert Pouwel Brouwer, Hugo Stoevelaar, Christoph Sucker